Evidence map›Paper›PMID 36447314›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2022

Key messages and partnerships to raise awareness and improve outcomes for people with asthma and COPD in low- and middle-income countries.

S Rylance, E D Bateman, L Boulet, M Cohen, A El Sony, D M G Halpin, E M Khoo, G B Marks, R Masekela, B Mikkelsen and 9 more

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Clinical standards for the diagnosis and management of asthma in low- and middle-income countries.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

S RylanceNoncommunicable Diseases Department, World Health Organization, Geneva, Switzerland.
E D BatemanGlobal Initiative for Asthma (GINA), Fontana, WI, USA, University of Cape Town Lung Institute, Cape Town, South Africa.
L BouletGlobal Initiative for Asthma (GINA), Fontana, WI, USA, Laval University, Quebec City, QC, Canada.
M CohenForum of International Respiratory Societies, Lausanne, Switzerland, Asociacion Latinoamericana de Torax, Montevideo, Uruguay, Hospital Centro Medico, Guatemala City, Guatemala.
A El SonyInternational Union Against Tuberculosis and Lung Disease, Paris, France, Epidemiological Laboratory (Epi-Lab) for Public Health, Research and Development, Khartoum, Sudan.
D M G HalpinGlobal Initiative for Obstructive Lung Disease (GOLD), Fontana, WI, USA, University of Exeter Medical School, Exeter, UK.
E M KhooInternational Primary Care Respiratory Group (IPCRG), Edinburgh, UK, Department of Primary Care Medicine, University of Malaya, Kuala Lumpur, Malaysia.
G B MarksInternational Union Against Tuberculosis and Lung Disease, Paris, France, University of New South Wales, Sydney, NSW, Australia.
R MasekelaInternational Union Against Tuberculosis and Lung Disease, Paris, France, Global Asthma Network (GAN), Auckland, New Zealand, Pan African Thoracic Society, Congella, South Africa, Department of Paediatrics and Child Health, University of KwaZulu Natal, Durban, South Africa.
B MikkelsenNoncommunicable Diseases Department, World Health Organization, Geneva, Switzerland.
K J MortimerGlobal Initiative for Asthma (GINA), Fontana, WI, USA, International Union Against Tuberculosis and Lung Disease, Paris, France, Global Initiative for Obstructive Lung Disease (GOLD), Fontana, WI, USA, Global Asthma Network (GAN), Auckland, New Zealand, Aintree University Hospital, Liverpool, UK.
J Chakaya MuhwaInternational Union Against Tuberculosis and Lung Disease, Paris, France, Kenyatta University, Nairobi, Kenya.
I Nunes da CunhaInternational Pharmaceutical Federation, The Hague, Netherlands.
A ŠajnićInternational Coalition of Respiratory Nurses, University Hospital Centre Zagreb, Croatia.
S SalviGlobal Initiative for Obstructive Lung Disease (GOLD), Fontana, WI, USA, Pulmocare Research and Education Foundation, Pune, India.
S SlamaNoncommunicable Diseases Department, World Health Organization, Geneva, Switzerland.
T WindersGlobal Allergy and Airways Patient Platform, Vienna, Austria.
A YorganciogluGlobal Initiative for Asthma (GINA), Fontana, WI, USA, Celal Bayar University, Manisa, Turkey.
H J ZarForum of International Respiratory Societies, Lausanne, Switzerland, Pan African Thoracic Society, Congella, South Africa, SA Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaPulmonary Disease, Chronic ObstructiveDeveloping CountriesHumansIncome

Identifiers

PMID36447314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.